Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A Qualitative Study of Lived Treatment Experiences and Preferences of Long-Term DMT Users with Relapsing-Remitting Multiple Sclerosis.
Therapeutic reactivation of hippocampal progenitors reverse cognition decline in mice with progressive brain demyelination.
Structural Characterization, Toxicity Assessment and Molecular Modeling of Forced Degradation Products of Siponimod.
PIEZOs regulate oligodendrocyte sheath formation, expansion, and myelination potential.
Acute Water Intoxication Leading to Dilutional Hyponatremia in a Patient With Urinary Tract Infection: A Case Report.
Sex-Specific Differences in Amino Acids and Neurotransmitters in Multiple Sclerosis Patients Compared to Non-Neuroinflammatory Controls: A Retrospective Case-Control Study.
MOG-IgG Positivity Does Not Equal MOGAD: Diagnostic Pitfall and Misapplication of the International MOGAD Panel Proposed Criteria in Real-World Practice.
[Effects of electroacupuncture on HMGB1/RAGE/NF-κB pathway-mediated inflammatory response and reactive astrocyte in Parkinson's disease mice].
Functional Connectivity Alterations of the Central Autonomic Network in Multiple Sclerosis: Links to Fatigue and Aerobic Training Effects.
TIM-3-dependent lysosome biogenesis is required for myelin debris clearance in macrophages.
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
[Prospects for retroelement-targeted therapy of schizophrenia].
Psychosis in multiple sclerosis-a narrative review of an underestimated, but clinically significant problem.
Updated systematic literature review and network meta-analysis of cladribine tablets versus currently approved disease-modifying treatments for active relapsing-remitting multiple sclerosis.
Depletion of promotes neuroinflammatory attack against myelin in an experimental autoimmune encephalomyelitis mouse model.
C3 and C5 complement cascade activation in brain injury and disease: Molecular mechanisms, pathological roles, and therapeutic implications.
MIF Tautomerase Inhibition Protects Neurons From Immune-Mediated Cell Death.
Feasibility and Validity of a Remotely-Administered 30-Second Sit-to-Stand in People with Multiple Sclerosis.
Neuromyelitis optica spectrum disorder in a patient with neurofibromatosis type 1 mimicking spinal cord infarction.
Predictors of relapses in patients with chronic inflammatory demyelinating polyneuropathy receiving subcutaneous immunoglobulin therapy - a post-hoc analysis.
Status for and associations between disability, employment, barriers for work and health-related quality of life in individuals with multiple sclerosis: A cross-sectional study.
The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.
Methodological considerations in evaluating lifetime estrogen exposure and neurodegeneration in multiple sclerosis.
Genetic Prognostic Factors in Multiple Sclerosis: Key Discoveries and Unmet Needs.
Chronic optic neuropathy: correlating MR imaging features and etiology.

Pages